资讯
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
16 小时
Capital Market on MSNShilpa Medicare gains as unit VI gets USFDA EIR with VAI classificationShilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka, India. The ...
Orthopedic surgeons are now able to take Subspecialty Certification Examinations offered by the American Board of Orthopaedic ...
A former West Des Moines dentist who has been sued six times for medical malpractice has been sanctioned for the third time by the Iowa Dental Board.
Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果